ARTICLE | Clinical News
Prolaris: Postmarketing study data
March 10, 2014 7:00 AM UTC
The prospective PROCEDE 500 registry study in 305 prostate cancer patients showed that physicians said that they would change their treatment plans in 65% of cases after receiving results from Myriad'...